{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:25:01Z","timestamp":1793348701216,"version":"4.5.0"},"reference-count":40,"publisher":"American Association for Cancer Research (AACR)","issue":"11","funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>FOXP3+ regulatory T cells (Treg) play a critical role in mediating tolerance to self-antigens and can repress antitumor immunity through multiple mechanisms. Therefore, targeted depletion of tumor-resident Tregs is warranted to promote effective antitumor immunity while preserving peripheral homeostasis. Here, we propose the chemokine receptor CCR8 as one such optimal tumor Treg target. CCR8 was expressed by Tregs in both murine and human tumors, and unlike CCR4, a Treg depletion target in the clinic, CCR8 was selectively expressed on suppressive tumor Tregs and minimally expressed on proinflammatory effector T cells (Teff). Preclinical mouse tumor modeling showed that depletion of CCR8+ Tregs through an FcyR-engaging anti-CCR8 antibody, but not blockade, enabled dose-dependent, effective, and long-lasting antitumor immunity that synergized with PD-1 blockade. This depletion was tumor Treg-restricted, sparing CCR8+ T cells in the spleen, thymus, and skin of mice. Importantly, Fc-optimized, nonfucosylated (nf) anti-human CCR8 antibodies specifically depleted Tregs and not Teffs in ex vivo tumor cultures from primary human specimens. These findings suggest that anti\u2013CCR8-nf antibodies may deliver optimal tumor-targeted Treg depletion in the clinic, providing long-term antitumor memory responses while limiting peripheral toxicities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>These findings show that selective depletion of regulatory T cells with an anti-CCR8 antibody can improve antitumor immune responses as a monotherapy or in combination with other immunotherapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-20-3585","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T15:05:22Z","timestamp":1616511922000},"page":"2983-2994","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models"],"prefix":"10.1158","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3887-2309","authenticated-orcid":false,"given":"Joseph R.","family":"Campbell","sequence":"first","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan R.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Mesko","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan O.","family":"Siemers","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti B.","family":"Singh","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4421-6770","authenticated-orcid":false,"given":"Mark","family":"Selby","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim W.","family":"Sproul","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1142-8542","authenticated-orcid":false,"given":"Alan J.","family":"Korman","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan M.","family":"Vlach","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Houser","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Sambanthamoorthy","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lu","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra V.","family":"Hatcher","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Lohre","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Jain","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-2271","authenticated-orcid":false,"given":"Ruth Y.","family":"Lan","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Redwood City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"2022061706392592900_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"2022061706392592900_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"2022061706392592900_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"2022061706392592900_bib4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","article-title":"Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells","volume":"16","author":"Yagi","year":"2004","journal-title":"Int Immunol"},{"key":"2022061706392592900_bib5","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"2022061706392592900_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coi.2015.02.003","article-title":"The interplay of effector and regulatory T cells in cancer","volume":"33","author":"Roychoudhuri","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"2022061706392592900_bib7","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1158\/0008-5472.CAN-10-1681","article-title":"Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth","volume":"70","author":"Teng","year":"2010","journal-title":"Cancer Res"},{"key":"2022061706392592900_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40425-016-0140-2","article-title":"Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial","volume":"4","author":"Luke","year":"2016","journal-title":"J Immunother Cancer"},{"key":"2022061706392592900_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/2326-6066.CIR-13-0013","article-title":"Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells","volume":"1","author":"Selby","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"2022061706392592900_bib10","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1084\/jem.20130579","article-title":"Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti\u2013CTLA-4 therapy against melanoma","volume":"210","author":"Simpson","year":"2013","journal-title":"J Exp Med"},{"key":"2022061706392592900_bib11","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1158\/1078-0432.CCR-19-0402","article-title":"Anti-CTLA-4 immunotherapy does not deplete FOXP3+ regulatory T cells (Tregs) in human cancers-response","volume":"25","author":"Sharma","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2022061706392592900_bib12","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1158\/1078-0432.CCR-15-0357","article-title":"Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients","volume":"21","author":"Kurose","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2022061706392592900_bib13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.immuni.2016.10.032","article-title":"Regulatory T cells exhibit distinct features in human breast cancer","volume":"45","author":"Plitas","year":"2016","journal-title":"Immunity."},{"key":"2022061706392592900_bib14","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells","volume":"45","author":"De Simone","year":"2016","journal-title":"Immunity"},{"key":"2022061706392592900_bib15","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1172\/JCI130426","article-title":"IRF4 instructs effector Treg differentiation and immune suppression in human cancer","volume":"130","author":"Alvisi","year":"2020","journal-title":"J Clin Invest"},{"key":"2022061706392592900_bib16","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1158\/1078-0432.CCR-08-1825","article-title":"Anti\u2013programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor\u2013secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors","volume":"15","author":"Li","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2022061706392592900_bib17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","article-title":"Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing","volume":"24","author":"Guo","year":"2018","journal-title":"Nat Med"},{"key":"2022061706392592900_bib18","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"2022061706392592900_bib19","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1093\/nar\/gkz655","article-title":"LTMG: a novel statistical modeling of transcriptional expression states in single-cell RNA-Seq data","volume":"47","author":"Wan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2022061706392592900_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4049\/jimmunol.1101845","article-title":"Adenosine A 2BReceptor blockade slows growth of bladder and breast tumors","volume":"188","author":"Cekic","year":"2011","journal-title":"J Immunol"},{"key":"2022061706392592900_bib21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4 + CD25 + Foxp3 + regulatory T cells induce cytokine deprivation\u2013mediated apoptosis of effector CD4 + T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat Immunol"},{"key":"2022061706392592900_bib22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"2022061706392592900_bib23","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.4049\/jimmunol.181.9.6664","article-title":"Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions","volume":"181","author":"Baudino","year":"2008","journal-title":"J Immunol"},{"key":"2022061706392592900_bib24","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1073\/pnas.1014515107","article-title":"Fc\u03b3RIV deletion reveals its central role for IgG2a and IgG2b activity in vivo","volume":"107","author":"Nimmerjahn","year":"2010","journal-title":"PNAS"},{"key":"2022061706392592900_bib25","doi-asserted-by":"crossref","first-page":"e0200765","DOI":"10.1371\/journal.pone.0200765","article-title":"CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction","volume":"13","author":"Thyagarajan","year":"2018","journal-title":"PLoS One"},{"key":"2022061706392592900_bib26","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.4049\/jimmunol.1701377","article-title":"CCR8 expression defines tissue-resident memory T cells in human skin","volume":"200","author":"McCully","year":"2018","journal-title":"J Immunol"},{"key":"2022061706392592900_bib27","first-page":"103","article-title":"In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells","volume":"51","author":"Le Gros","year":"1984","journal-title":"Immunology"},{"key":"2022061706392592900_bib28","doi-asserted-by":"crossref","first-page":"117ra7","DOI":"10.1126\/scitranslmed.3003008","article-title":"Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients","volume":"4","author":"Clark","year":"2012","journal-title":"Sci Transl Med"},{"key":"2022061706392592900_bib29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2568","article-title":"Sensing and alarm function of resident memory CD8+ T cells","volume":"14","author":"Schenkel","year":"2013","journal-title":"Nat Immunol"},{"key":"2022061706392592900_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"Fc\u03b3RIV: A novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"key":"2022061706392592900_bib31","doi-asserted-by":"crossref","first-page":"9730","DOI":"10.1073\/pnas.93.18.9730","article-title":"The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product","volume":"93","author":"Huang","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"2022061706392592900_bib32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2005","journal-title":"Nature"},{"key":"2022061706392592900_bib33","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1158\/1078-0432.CCR-05-2619","article-title":"Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to Fc RIIIa","volume":"12","author":"Iida","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2022061706392592900_bib34","doi-asserted-by":"crossref","first-page":"12161","DOI":"10.1128\/JVI.75.24.12161-12168.2001","article-title":"Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1","volume":"75","author":"Hezareh","year":"2001","journal-title":"J Virol"},{"key":"2022061706392592900_bib35","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41590-019-0429-7","article-title":"Connecting blood and intratumoral T reg cell activity in predicting future relapse in breast cancer","volume":"20","author":"Wang","year":"2019","journal-title":"Nat Immunol"},{"key":"2022061706392592900_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2018.08.007","article-title":"A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity","volume":"95","author":"Kumar","year":"2018","journal-title":"J Autoimmun"},{"key":"2022061706392592900_bib37","first-page":"201822001","article-title":"PD-1 +regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer","volume":"15","author":"Kamada","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"2022061706392592900_bib38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2007-11-125435","article-title":"CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion","volume":"112","author":"Kavanagh","year":"2008","journal-title":"Blood"},{"key":"2022061706392592900_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br J Cancer"},{"key":"2022061706392592900_bib40","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3322\/caac.21498","article-title":"Local cancer recurrence: the realities, challenges, and opportunities for new therapies","volume":"68","author":"Mahvi","year":"2018","journal-title":"CA Cancer J Clin"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/81\/11\/2983\/3085413\/2983.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/81\/11\/2983\/3085413\/2983.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T16:37:18Z","timestamp":1698079038000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/81\/11\/2983\/673682\/Fc-Optimized-Anti-CCR8-Antibody-Depletes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,3,23]]},"published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-20-3585","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22430332.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430326.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430347.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6513598.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430341.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430350","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430341","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430344.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430338.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430332","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430350.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430344","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430335","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430347","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430326","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430335.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430338","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430329.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22430329","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6513598","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]}}}